Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Nasopharyngeal Cancer Progressing After Platinum-based Chemotherapy
NCT04875611Phase 2Recruiting
- Sponsor
- Maria Skłodowska-Curie National Research Institute of Oncology
- Start
- Aug 2021
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2 trial of nivolumab in nasopharyngeal carcinoma (NPC), sponsored by Maria Skłodowska-Curie National Research Institute of Oncology. Started Aug 2021; status: recruiting.
02
Drugs
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04875611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875611.